The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Constantin N. Baxevanis sits on this spectrum.
This scientist: 201 publications — 35th percentile
35% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 807 publications or more.
The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Constantin N. Baxevanis sits on this spectrum.
This scientist: 53 D-Index — 20th percentile
20% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 157 D-Index or more.
Constantin N. Baxevanis is affiliated with St Savas Hospital in Greece and has an extensive publication record focused primarily on medicine, immunology, and oncology. Their research portfolio includes significant contributions to the fields of cancer immunotherapy, immune response mechanisms, and biomarkers relevant to cancer diagnostics and treatment.
The scientist's work spans various interconnected subfields, notably oncology, immunology, pulmonary and respiratory medicine, cancer research, and molecular biology. They have published extensively on topics such as cancer immunotherapy and biomarkers, immunotherapy and immune responses, prostate cancer treatment and research, cancer genomics and diagnostics, ferroptosis and cancer prognosis, immune cell function and interaction, and cancer-related molecular mechanisms research.
Among their recent publications are the following papers:
The body of work published by Constantin N. Baxevanis appears prominently in several scientific venues. Key journals in which the scientist has published multiple articles include:
Collaboration forms a significant part of their research activity. Frequent coauthors include:
Their scientific contributions center around advancing the understanding of immunotherapy and biomarker development in cancer treatment, with a notable focus on translating molecular and genomic discoveries into clinical applications. The continued exploration of mechanisms such as immune checkpoint inhibition and DNA damage response highlights an ongoing engagement with therapeutic innovation and cancer patient outcomes.
Panagiota A. Sotiropoulou;Sonia A. Perez;Angelos D. Gritzapis;Constantin N. Baxevanis
Panagiota A. Sotiropoulou;Sonia A. Perez;Maria Salagianni;Constantin N. Baxevanis
Jan Klein;Antonio JuretiĆ;Antonio JuretiĆ;Constantin N. Baxevanis;Zoltan A. Nagy
Nikolaos G. Papadopoulos;George V.Z. Dedoussis;Gregory Spanakos;Angelos D. Gritzapis
Eleni G. Iliopoulou;Panteleimon Kountourakis;Michalis V. Karamouzis;Dimitrios Doufexis
St. Theodoropoulou;G. Spanakos;C.N. Baxevanis;M. Economou
Olga Katsara;Louisa G. Mahaira;Eleni G. Iliopoulou;Ardiana Moustaki
Constantin N. Baxevanis;Ioannis F. Voutsas;Ourania E. Tsitsilonis;Angelos D. Gritzapis
Zoltan A. Nagy;Constantin N. Baxevanis;Norihisa Ishii;Jan Klein
Constantin N. Baxevanis;Sonia A. Perez;Michael Papamichail
Michael Papamichail;Sonia A. Perez;Angelos D. Gritzapis;Constantin N. Baxevanis
Unknown
Constantin N. Baxevanis;George J. Reclos;Angelos D. Gritzapis;George V. Z. Dedousis
Sonia A. Perez;Eric von Hofe;Nikoletta L. Kallinteris;Angelos D. Gritzapis
Constantin N. Baxevanis;George V. Z. Dedoussis;Nikolaos G. Papadopoulos;Ioannis Missitzis
Michael Sofopoulos;Sotirios P Fortis;Christoforos K Vaxevanis;Nectaria N Sotiriadou
Panagiota A. Sotiropoulou;Sonia A. Perez;Maria Salagianni;Constantin N. Baxevanis
Sonia A. Perez;Michael V. Karamouzis;Dimosthenes V. Skarlos;Alexandros Ardavanis
Constantin N. Baxevanis;Sotirios P. Fortis;Sonia A. Perez
Constantin N. Baxevanis;Konstantinos Papilas;George V.Z. Dedoussis;Theodor Pavlis
Constantin N. Baxevanis;Ioannis F. Voutsas;Ourania E. Tsitsilonis;Marinos L. Tsiatas
Constantin N. Baxevanis;Nectaria N. Sotiriadou;Angelos D. Gritzapis;Panagiota A. Sotiropoulou
R Sotiriadou;S A Perez;A D Gritzapis;Panagiota Sotiropoulou
Constantin N. Baxevanis;Panagiota A. Sotiropoulou;Nectaria N. Sotiriadou;Michael Papamichail
If you think any of the details on this page are incorrect, let us know.
Studying immunology opens doors to various healthcare careers, many of which benefit from advanced nursing degrees. For those interested in elevating their practice, exploring acnp programs can be a pivotal step towards specializing in acute care nursing.
Accelerated pathways are increasingly popular for those who want to transition quickly into nursing roles. The accelerated nurse practitioner programs offer a dynamic route for students who already hold a bachelor’s degree in another field to pursue nursing at an advanced level without losing time.
For individuals without a nursing background, the best online bsn programs for non nurses provide accessible options to enter the nursing profession, establishing a strong foundation for future specialization in fields like immunology.
Salary expectations are also an important consideration when planning a career. Understanding how much do dnp nurses make can help guide your educational investments and career choices within the healthcare field.
Pennsylvania State University
Okinawa Institute of Science and Technology
Guangxi University
Lincoln University
University of Chicago
Emory University
Wake Forest University
KU Leuven
Microsoft (United States)
Wuhan University
Harvard University
Istanbul University
University of Tokyo
University of Pittsburgh
Grenoble Alpes University
Harvard University
